Narrow search
Showing 1 - 10 of 348
Cover Image
Health care reform and the number of doctor visits : an econometric analysis
Winkelmann, Rainer (contributor) - 2002 - [Elektronische Ressource]
The paper evaluates the German health care reform of 1997, using the individual number of doctor visits as outcome measure and data from the German Socio- Economic Panel for the years 1995-1999. A number of modified count data models allow to estimate the effect of the reform in different parts...
Persistent link: https://www.econbiz.de/10001729424
Cover Image
Re-evaluating an evaluation study : the case of the German health care reform of 1997
Winkelmann, Rainer (contributor) - 2003 - [Elektronische Ressource]
This paper reports on a re-evaluation of the German health care reform of 1997. A previous evaluation found a limited effect of a 4.4 percent reduction of the number of doctor visits in a sample of pharmacy customers. The re-evaluation based on a representative household survey, the German...
Persistent link: https://www.econbiz.de/10001807289
Cover Image
How did the German health care reform of 1997 change the distribution of the demand for health services?
Winkelmann, Rainer (contributor) - 2003 - [Elektronische Ressource]
I consider the problem of evaluating the effect of a health care reform on the demand for doctor visits when the effect …
Persistent link: https://www.econbiz.de/10001957001
Cover Image
A pharmaceutical innovation : is it worth the money? Whose money?
Sennhauser, Michèle; Zweifel, Peter - 2009
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791
Cover Image
Consumer resistance against regulation : the case of health care
Zweifel, Peter (contributor); Telser, Harry (contributor);  … - 2005
Regulation fostering Managed Care alternatives in health insurance is spreading. This work reports on an experiment designed to measure the amounts of compensation asked by the Swiss population (in terms of reduced premiums) for Managed-Care type restrictions in the provision of health care. It...
Persistent link: https://www.econbiz.de/10002746136
Cover Image
Empirical implications of physician authority in pharmaceutical decisionmaking
Stern, Scott; Trajtenberg, Manuel - 1998
Persistent link: https://www.econbiz.de/10000997856
Cover Image
A taste of their own medicine : guideline adherence and access to expertise
Finkelstein, Amy; Persson, Petra; Polyakova, Maria; … - 2021
Persistent link: https://www.econbiz.de/10012632073
Cover Image
On the demand for telemedicine : evidence from the Covid-19 pandemic
Busso, Matias; Gonzalez, Maria P.; Scartascini, Carlos G. - 2021
Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine … demand for telemedicine experienced after the onset of the COVID-19 epidemic and the imposition of mobility restrictions. We … service for internal medicine consultations. The demand for telemedicine remains high even after mobility restrictions were …
Persistent link: https://www.econbiz.de/10012586138
Cover Image
Physician dispensing and the choice between generic and brand-name drugs : do margins affect choice?
Rischatsch, Maurus; Trottmann, Maria - 2009
analyze the prescribing behavior of Swiss physicians using cross-sectional data between 2005 and 2007 for three important … agents. The results support our hypothesis that dispensing physicians have a higher probability of prescribing the drug with … the (most likely) higher margin compared to non-dispensing physicians. Further, generic drugs are prescribed more often to …
Persistent link: https://www.econbiz.de/10003900934
Cover Image
Drug quality and safety issues in India
Chokshi, Maulik; Mongia, Rahul; Wattal, Vasudha - 2015
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690